Overview

Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY)

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Evaluation of safety of a concentration controlled testosterone enanthate QuickShot Testosterone regimen administered subcutaneously once each week to adult males with hypogonadism.
Phase:
Phase 3
Details
Lead Sponsor:
Antares Pharma Inc.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate